Lam Research
LRCX
$252.35
-6.40%
Lam Research is a leading supplier of semiconductor wafer fabrication equipment, specializing in deposition and etch processes critical to manufacturing advanced chips. As the market share leader in etch and the clear second in deposition, the company holds a dominant position in the semiconductor capital equipment industry, serving top-tier customers like TSMC, Samsung, Intel, and Micron. The current investor narrative centers on Lam's pivotal role in enabling AI chip production, with record revenue and accelerating growth driven by AI infrastructure build-out, though recent volatility reflects concerns about sector overvaluation and geopolitical risks.…
LRCX
Lam Research
$252.35
Related headlines
Investment Opinion: Should I buy LRCX Today?
Rating: Buy. Thesis: Lam Research is a high-quality growth stock benefiting from secular AI demand, with accelerating revenue and expanding margins, but investors should size positions carefully given the elevated forward P/E. The analyst consensus is Strong Buy with an average target of $372.32, implying 22% upside.
Supporting Evidence: Revenue grew 23.8% YoY to $5.84B, well above the industry average of ~10%. Net margin expanded to 31.2% from 28.2%, and operating margin improved to 35.0%. Free cash flow of $6.45B provides strong internal funding. The trailing P/E of 23.3x is near the middle of its historical range (8.9x-34.6x), while the forward P/E of 37.5x reflects high growth expectations. The PEG ratio of 0.54 suggests the stock is undervalued relative to its growth rate.
Risks & Conditions: The biggest risks are a cyclical downturn in semiconductor spending, geopolitical disruptions, and failure to meet elevated growth expectations. This Buy would be downgraded to Hold if revenue growth decelerates below 15% or if the forward P/E expands above 40x. It would be upgraded to Strong Buy if the stock pulls back to $250 (20% downside) while fundamentals remain intact. Overall, Lam Research is fairly valued relative to its growth trajectory but carries premium valuation risk.
Sign up to view all
LRCX 12-Month Price Forecast
Lam Research is well-positioned to benefit from the multi-year AI infrastructure build-out, with strong revenue acceleration and margin expansion. The elevated forward P/E of 37.5x is justified by the PEG ratio of 0.54 and dominant market position, but leaves little room for error. The base case of 15-20% growth and a target of $372 is most likely, with a 50% probability. The bull case (30% probability) could drive the stock to $500 if AI demand accelerates, while the bear case (20% probability) could see a decline to $220 in a downturn. The stance is bullish with medium confidence due to valuation risk and cyclicality.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Lam Research's 12-month outlook, with a consensus price target around $372.32 and implied upside of +47.5% versus the current price.
Average Target
$372.32
0 analysts
Implied Upside
+47.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$220 - $500
Analyst target range
Lam Research is covered by 31 analysts, with a consensus recommendation of 'Strong Buy' (mean rating 1.49 on a 1-5 scale). The average target price is $372.32, implying approximately 22.0% upside from the current price of $305.21. The distribution leans heavily bullish, with no sell ratings and a majority of buy-equivalent ratings. Recent ratings from firms like Needham, Stifel, and Mizuho reaffirm positive views, reflecting confidence in the AI-driven growth story. The target price range spans from a low of $220.00 to a high of $500.00, a wide spread of $280 that signals high uncertainty about the stock's future trajectory. The high target of $500 implies a 63.8% upside and assumes continued acceleration in AI chip demand, multiple expansion, and successful execution on margin expansion. The low target of $220 suggests a 27.9% downside, pricing in risks such as a cyclical downturn in semiconductor spending, geopolitical disruptions, or margin compression. The wide spread indicates divergent views among analysts, with bulls focusing on AI tailwinds and bears wary of cyclicality and elevated valuations. The recent string of reaffirmations and upgrades suggests the consensus is leaning toward the bullish scenario.
Bulls vs Bears: LRCX Investment Factors
Lam Research presents a compelling growth story driven by AI infrastructure demand, with accelerating revenue (23.8% YoY), expanding margins (net margin 31.2%), and a dominant market position in etch and deposition. The bull case is supported by a Strong Buy analyst consensus and 22% average upside to target. However, the forward P/E of 37.5x is a significant premium to the industry, leaving the stock vulnerable to any growth disappointment or cyclical downturn. The single most important tension is whether the AI-driven demand cycle can sustain the high growth rates needed to justify the valuation, or if a cyclical correction or geopolitical shock will compress multiples. Currently, the bull case has stronger evidence given the record revenue and margin trends, but the elevated valuation demands careful monitoring.
Bullish
- Accelerating Revenue Growth: Revenue grew 23.8% YoY in Q3 FY2026 to $5.84B, marking the fourth consecutive quarter of accelerating growth from 10.5% in Q4 FY2025. This outpaces the semiconductor industry average of ~10%, driven by AI-driven demand for etch and deposition equipment.
- Dominant Market Position: Lam holds the #1 market share in etch and #2 in deposition, serving top customers like TSMC, Samsung, Intel, and Micron. This entrenched position provides a competitive moat and recurring revenue from customer support ($2.11B in Q3).
- Strong Profitability and Margins: Net margin expanded to 31.2% in Q3 FY2026 from 28.2% a year ago, with operating margin improving to 35.0% from 33.1%. ROE is an impressive 54.3%, reflecting efficient capital allocation and high returns on equity.
- Robust Free Cash Flow: Trailing twelve-month free cash flow is $6.45B, providing ample internal funding for growth investments and shareholder returns. The current ratio of 2.21 and debt-to-equity of 0.48 indicate a strong balance sheet.
Bearish
- Elevated Forward Valuation: The forward P/E of 37.5x represents a 70% premium to the semiconductor industry average of ~22x. This prices in optimistic growth expectations that must be delivered, leaving little room for error.
- Cyclical Industry Risk: Semiconductor capital equipment is highly cyclical; a downturn in chip spending could sharply reduce revenue. The stock's beta of 1.805 amplifies market moves, and the 1-month decline of -18.6% shows recent volatility.
- Geopolitical and Trade Risks: Exposure to China and memory chipmakers (DRAM/NAND) makes Lam vulnerable to export controls and trade tensions. Recent news of Samsung's 'sell the news' event highlights sector fragility.
- Wide Analyst Target Range: The analyst low target of $220 implies 27.9% downside from the current price of $305.21. The wide spread between low ($220) and high ($500) signals high uncertainty about future growth trajectory.
LRCX Technical Analysis
Lam Research is in a powerful long-term uptrend, with the stock up 212.1% over the past year, massively outperforming the S&P 500's 16.5% gain. The current price of $305.21 sits at 69.6% of its 52-week range ($90.94 to $438.50), indicating the stock is well off its highs but still in the upper half of the range. This positioning suggests the stock has pulled back from overbought levels but retains significant upward momentum from its lows. Short-term momentum has turned sharply negative, with a 1-month decline of -18.6% contrasting with a 3-month gain of 14.0% and a 1-year gain of 212.1%. This divergence signals a corrective pullback within a strong uptrend, possibly a mean-reversion after the explosive rally from April to June. The 1-month relative strength of -19.3% versus the S&P 500 confirms the stock is underperforming recently, but the 3-month relative strength of +10.5% shows the longer-term trend remains intact. The stock's beta of 1.805 indicates it is 80.5% more volatile than the market, amplifying both upside and downside moves. Key support lies at the 52-week low of $90.94, though a more immediate floor may be near the $300 psychological level. Resistance is at the 52-week high of $438.50; a breakout above that level would signal a resumption of the uptrend, while a breakdown below $300 could test the $250 area. The elevated beta means position sizing should account for higher-than-market risk.
Beta
1.80
1.80x market volatility
Max Drawdown
-41.8%
Largest decline past year
52-Week Range
$91-$439
Price range past year
Annual Return
+155.1%
Cumulative gain past year
| Period | LRCX Return | S&P 500 |
|---|---|---|
| 1m | -38.6% | -1.6% |
| 3m | -2.1% | +1.5% |
| 6m | +8.1% | +5.4% |
| 1y | +155.1% | +14.8% |
| ytd | +36.4% | +7.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LRCX Fundamental Analysis
Lam Research's revenue trajectory is strongly accelerating, with Q3 FY2026 (ending March 29, 2026) revenue of $5.84 billion, up 23.8% year-over-year from $4.72 billion in the prior-year quarter. This marks the fourth consecutive quarter of accelerating YoY growth, from 10.5% in Q4 FY2025 to 23.8% in Q3 FY2026. The growth is driven by both system sales ($3.73 billion) and customer support ($2.11 billion), with system sales benefiting from AI-driven demand for advanced etch and deposition equipment. The company is highly profitable, with net income of $1.83 billion in Q3 FY2026, representing a net margin of 31.2%, up from 28.2% a year ago. Gross margin expanded to 49.8% from 49.0% in the prior-year quarter, while operating margin improved to 35.0% from 33.1%, reflecting operating leverage and cost discipline. The balance sheet is robust, with a debt-to-equity ratio of 0.48 and a current ratio of 2.21, indicating ample liquidity. Free cash flow for the trailing twelve months is $6.45 billion, providing strong internal funding for growth and shareholder returns. Return on equity is an impressive 54.3%, underscoring efficient capital allocation and high profitability.
Quarterly Revenue
$5.8B
2026-03
Revenue YoY Growth
+23.8%
YoY Comparison
Gross Margin
49.8%
Latest Quarter
Free Cash Flow
$6.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LRCX Overvalued?
Given Lam Research's positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is 23.3x, while the forward P/E is 37.5x, implying the market expects significant earnings growth ahead. The gap between trailing and forward P/E suggests that analysts anticipate a sharp acceleration in EPS, consistent with the AI-driven demand narrative. Compared to the semiconductor industry average P/E of approximately 22x (based on sector data), Lam's trailing P/E of 23.3x is a modest 6% premium, but the forward P/E of 37.5x represents a 70% premium to the industry. This premium is justified by Lam's superior growth (23.8% YoY revenue growth vs. industry average of ~10%) and dominant market position in etch and deposition. Historically, Lam's trailing P/E has ranged from 8.9x (in Q1 FY2023) to 34.6x (in Q3 FY2026). The current 23.3x is near the middle of this range, suggesting the stock is not excessively overvalued relative to its own history. However, the forward P/E of 37.5x is near the high end, indicating that the market is pricing in optimistic growth expectations that must be delivered.
PE
71.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
59.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Lam Research's financial health is strong, but the high forward P/E of 37.5x creates valuation risk if growth decelerates. The company's revenue is concentrated in semiconductor capital equipment, which is inherently cyclical; a downturn in chipmaker CapEx could lead to a sharp revenue decline. While the debt-to-equity ratio is low at 0.48, the stock's beta of 1.805 means it is 80.5% more volatile than the market, amplifying downside in a selloff. Free cash flow of $6.45B provides a buffer, but any margin compression from rising costs or pricing pressure could impact profitability.
Market & Competitive Risks: The semiconductor equipment industry is competitive, with Applied Materials and Tokyo Electron as key rivals. Lam's premium valuation (forward P/E 37.5x vs. industry 22x) makes it susceptible to multiple compression if growth slows. Geopolitical risks, particularly US-China trade tensions and export controls, could disrupt sales to key customers. Recent news of a 'sell the news' event after Samsung's earnings highlights market sensitivity to overvaluation in AI-related sectors. The stock's 1-month decline of -18.6% versus the S&P 500's +0.78% gain underscores its vulnerability to sector rotation.
Worst-Case Scenario: In a severe downturn, semiconductor spending could contract, causing Lam's revenue to fall and margins to compress. The analyst low target of $220 implies a 27.9% downside from the current price of $305.21. The 52-week low of $90.94 represents a potential 70.2% decline, though this extreme scenario would require a catastrophic industry collapse. A more realistic worst case is a 30-40% decline to the $180-210 range, consistent with historical drawdowns and the low analyst target. Investors could lose up to 28% based on the low target, or more in a prolonged bear market.
FAQ
The key risks are: (1) Valuation risk: The forward P/E of 37.5x is high, and any growth disappointment could lead to multiple compression. (2) Cyclicality: Semiconductor capital equipment is cyclical; a downturn in chip spending could sharply reduce revenue and earnings. (3) Geopolitical risk: US-China trade tensions and export controls could disrupt sales to key customers like SMIC or memory makers. (4) Competitive risk: Rivals like Applied Materials and Tokyo Electron could gain share. The most severe risk is a 27.9% downside to the analyst low target of $220, or more in a prolonged bear market. The stock's beta of 1.805 amplifies market downturns.
The 12-month forecast is based on three scenarios: Bull case (30% probability) targets $400-$500, driven by accelerating AI demand and margin expansion. Base case (50% probability) targets $330-$400, with steady 15-20% growth and a forward P/E of 35-38x, aligning with the analyst average of $372. Bear case (20% probability) targets $220-$280, assuming a cyclical downturn or geopolitical shock. The most likely scenario is the base case, with the stock trading near $372. The AI assessment is bullish with medium confidence, citing strong revenue growth and a favorable PEG ratio, but cautioning on valuation and cyclicality.
Lam Research's trailing P/E of 23.3x is near the middle of its 5-year range (8.9x-34.6x) and only a 6% premium to the semiconductor industry average of ~22x, suggesting it is fairly valued on a trailing basis. However, the forward P/E of 37.5x represents a 70% premium to the industry, indicating the market is pricing in significant earnings growth. The PEG ratio of 0.54, based on expected EPS growth, suggests the stock is undervalued relative to its growth rate. Compared to its own history, the current valuation is not extreme, but the forward multiple leaves little room for error. The market is expecting continued acceleration in AI-driven demand, and if that materializes, the stock could be considered undervalued.
Lam Research is a good buy for growth-oriented investors with a long-term horizon, given its accelerating revenue (23.8% YoY), strong margins (net margin 31.2%), and dominant position in semiconductor equipment. The analyst consensus is Strong Buy with an average target of $372.32, implying 22% upside from the current price of $305.21. However, the forward P/E of 37.5x is elevated, and the stock has high volatility (beta 1.805), so it is not suitable for risk-averse investors. The biggest downside risk is a cyclical downturn or geopolitical shock, which could drive the stock to the low target of $220 (27.9% downside). For those who believe in the multi-year AI growth story, LRCX offers a compelling risk/reward at current levels, especially with a PEG ratio of 0.54 indicating undervaluation relative to growth.
Lam Research is best suited for long-term investment (3-5 years) given its secular growth driver in AI and dominant market position. The stock's high beta of 1.805 and recent 1-month decline of -18.6% make it volatile for short-term trading, though active traders could capitalize on swings. The dividend yield is low at 0.92%, so income investors should look elsewhere. For long-term holders, the company's strong free cash flow ($6.45B TTM) and ROE of 54.3% support compounding. A minimum holding period of 3 years is recommended to ride out cyclical downturns and benefit from AI adoption. Short-term investors should be aware of the wide 52-week range ($90.94-$438.50) and potential for sharp corrections.